References
- Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
- Barenholz Y. (2012). Doxil®-the first FDA-approved nano-drug: lessons learned. J Control Release 160:117–34.
- Chiu GNC, Abraham SA, Ickenstein LM, et al. (2005). Encapsulatuon of doxorubicin into thermosensitive liposomes via complexation with transition metal manganese. J Control Release 104:271–88.
- Costley D, Mc Ewan C, Fowley C, et al. (2015). Treating cancer with sonodynamic therapy: a review. Int J Hyperthermia 31:107–17.
- Husseini GA, Pitt WG, Martins AM. (2014). Ultrasonically triggered drug delivery: breaking the barrier. Colloids Surf B Biointerfaces 123:364–86.
- Kessel D, Lo J, Jeffers R, et al. (1995). Modes of photodynamic vs. sonodynamic cytotoxicity. J Photochem Photobiol B Biol 28:219–21.
- Khawar IA, Kim JH, Kuh HJ. (2015). Improving drug delivery to solid tumors: priming the tumor microenvironment. J. Control Release 201:78–89.
- Lajunen T, Kontturi LS, Viitala L, et al. (2016). Indocyanine green-loaded liposomes for light-triggered drug release. Mol Pharm 13:2095–107.
- Li L, ten Hagen TLM, Hossann M, et al. (2013). Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release 168:142–50.
- Li MY, Li ZP, Yang Y, et al. (2016). Thermo-sensitive liposome co-loaded of vincristine and doxorubicin based on their similar physicochemical properties had synergism on tumor treatment. Pharm Res 33:1881–98.
- Misìk V, Riesz P. (2000). Free radical intermediates in sonodynamic therapy. Ann N Y Acad Sci 899:335–48.
- Qiu D, An X. (2013). Controllable release from magnetoliposomes by magnetic stimulation and thermal stimulation. Colloids Surf B Biointerfaces 104:326–9.
- Rosenthal I, Sostaric JZ, Riesz P. (2004). Sonodynamic therapy–a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11:349–63.
- Tian Z, Quan X, Xu C, et al. (2009). Hematoporphyrin monomethyl ether enhances the killing action of ultrasound on osteosarcoma in vivo. J Ultrasound Med 28:1695–702.
- Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–60.
- Torchilin VP. (2012). Multifunctional nanocarriers. Adv Drug Delivery Rev 64:302–15.
- Xie XY, Yang YF, Lin W, et al. (2015). Cell-penetrating peptide-siRNA conjugate loaded YSA-modified nanobubbles for ultrasound triggered siRNA delivery. Colloids and Surf B Biointerfaces 136:641–50.
- Zhang L, Gu FX, Chan JM, et al. (2008). Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83:761–9.
- Zhang H, Wang ZY, Gong W, et al. (2011). Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate. Int J Pharm 414:56–62.
- Zhao C, Shao L, Lu J, et al. (2017). Triple redox responsive poly(ethylene glycol)-polycaprolactone polymeric nanocarriers for fine-controlled drug release. Macromol Biosci 17:1600295.
- Zhigaltsev IV, Maurer N, Akhong Q-F, et al. (2005). Liposome-encapsulated vincristine, vinblastine and vinorelbine: a comparative study of drug loading and retention. J Control Release 104:103–11.